BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19712456)

  • 1. Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways.
    Rasheed S; Yan JS; Hussain A; Lai B
    J Transl Med; 2009 Aug; 7():75. PubMed ID: 19712456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.
    Ganju RK; Munshi N; Nair BC; Liu ZY; Gill P; Groopman JE
    J Virol; 1998 Jul; 72(7):6131-7. PubMed ID: 9621077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
    Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
    Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function.
    Yang WS; Lin TY; Chang L; Yeh WW; Huang SC; Chen TY; Hsieh YT; Chen ST; Li WC; Pan CC; Campbell M; Yen CH; Chen YA; Chang PC
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31723026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.
    Albini A; Soldi R; Giunciuglio D; Giraudo E; Benelli R; Primo L; Noonan D; Salio M; Camussi G; Rockl W; Bussolino F
    Nat Med; 1996 Dec; 2(12):1371-5. PubMed ID: 8946838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
    Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
    Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Barillari G; Ensoli B
    Clin Microbiol Rev; 2002 Apr; 15(2):310-26. PubMed ID: 11932235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.
    Albini A; Fontanini G; Masiello L; Tacchetti C; Bigini D; Luzzi P; Noonan DM; Stetler-Stevenson WG
    AIDS; 1994 Sep; 8(9):1237-44. PubMed ID: 7528513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic properties of human immunodeficiency virus type 1 Tat protein.
    Albini A; Barillari G; Benelli R; Gallo RC; Ensoli B
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4838-42. PubMed ID: 7539135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
    Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
    Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS
    Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults.
    Nana BC; Esemu LF; Besong ME; Atchombat DHN; Ogai K; Sobgui TMP; Nana CMM; Seumko'o RMN; Awanakan H; Ekali GL; Leke RGF; Okamoto S; Ndhlovu LC; Megnekou R
    Front Immunol; 2023; 14():1216480. PubMed ID: 37809059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway.
    Zhou F; Xue M; Qin D; Zhu X; Wang C; Zhu J; Hao T; Cheng L; Chen X; Bai Z; Feng N; Gao SJ; Lu C
    PLoS One; 2013; 8(1):e53145. PubMed ID: 23301033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.
    Barillari G; Sgadari C; Fiorelli V; Samaniego F; Colombini S; Manzari V; Modesti A; Nair BC; Cafaro A; Stürzl M; Ensoli B
    Blood; 1999 Jul; 94(2):663-72. PubMed ID: 10397733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?
    Samaniego F; Pati S; Karp JE; Prakash O; Bose D
    J Natl Cancer Inst Monogr; 2001; (28):15-23. PubMed ID: 11158202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.